Benzinga | Sep 28, 2020 08:02AM EDT

Masimo Announces FDA Clearance Of The Rad-G Pulse Oximeter

Masimo (NASDAQ:MASI) announced today FDA clearance of the Rad-G(tm) Pulse Oximeter, a rugged handheld device that provides clinically proven SET(r) pulse oximetry, respiration rate from the pleth (RRp(r)), and other vital parameters for both spot-checking and continuous monitoring. With its long-lasting rechargeable battery, robust rubber casing, light weight, and a convenient new direct-connect sensor capable of monitoring both adults and children, Rad-G makes it easier for clinicians to quickly assess patients and make informed care decisions anywhere pulse oximetry or vital signs checking is needed in a compact, portable form factor. Providing the ultimate in handheld versatility, Rad-G can be used in a variety of settings, including but not limited to physicians' offices, outpatient services, long-term care facilities, wellness clinics, first-response scenarios, and limited-resource environments.